{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "25", "@timestamp": "2024-10-25T09:49:55.000055-04:00", "@year": "2024", "@month": "10"}, "ait:date-sort": {"@day": "01", "@year": "2016", "@month": "12"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "address-part": "Thai Red Cross Society", "@afid": "60022183", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Chulalongkorn Center of Excellence for Parkinson Disease & Related Disorders"}, {"$": "Department of Medicine"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University and King Chulalongkorn Memorial Hospital"}], "affiliation-id": [{"@afid": "60022183", "@dptid": "100291259"}, {"@afid": "60031780"}, {"@afid": "60028190"}], "@dptid": "100291259"}, "author": [{"ce:given-name": "Roongroj", "preferred-name": {"ce:given-name": "Roongroj", "ce:initials": "R.", "ce:surname": "Bhidayasiri", "ce:indexed-name": "Bhidayasiri R."}, "@seq": "1", "ce:initials": "R.", "@_fa": "true", "@type": "auth", "ce:surname": "Bhidayasiri", "@auid": "55882458500", "@orcid": "0000-0002-6901-2064", "ce:indexed-name": "Bhidayasiri R."}]}, {"affiliation": {"country": "Japan", "@afid": "60032116", "@country": "jpn", "city": "Tokyo", "organization": [{"$": "Department of Rehabilitation Medicine"}, {"$": "Juntendo University"}], "affiliation-id": {"@afid": "60032116", "@dptid": "112543792"}, "@dptid": "112543792"}, "author": [{"ce:given-name": "Roongroj", "preferred-name": {"ce:given-name": "Roongroj", "ce:initials": "R.", "ce:surname": "Bhidayasiri", "ce:indexed-name": "Bhidayasiri R."}, "@seq": "1", "ce:initials": "R.", "@_fa": "true", "@type": "auth", "ce:surname": "Bhidayasiri", "@auid": "55882458500", "@orcid": "0000-0002-6901-2064", "ce:indexed-name": "Bhidayasiri R."}]}, {"affiliation": {"country": "Spain", "@afid": "60026796", "@country": "esp", "city": "Madrid", "organization": [{"$": "Movement Disorders Unit"}, {"$": "Department of Neurology"}, {"$": "Fundacion Jimenez Diaz"}, {"$": "Universidad Autonoma de Madrid"}], "affiliation-id": {"@afid": "60026796", "@dptid": "108058480"}, "@dptid": "108058480"}, "author": [{"ce:given-name": "Pedro J.", "preferred-name": {"ce:given-name": "Pedro J.", "ce:initials": "P.J.", "ce:surname": "Garcia Ruiz", "ce:indexed-name": "Garcia Ruiz P.J."}, "@seq": "2", "ce:initials": "P.J.", "@_fa": "true", "@type": "auth", "ce:surname": "Garcia Ruiz", "@auid": "7005540950", "ce:indexed-name": "Garcia Ruiz P.J."}]}, {"affiliation": {"country": "Denmark", "address-part": "Bispebjerg Bakke 23", "postal-code": "2400", "@afid": "60025840", "@country": "dnk", "city": "Copenhagen", "organization": [{"$": "Movement Disorder Clinic"}, {"$": "University Hospital of Bispebjerg"}], "affiliation-id": {"@afid": "60025840", "@dptid": "115442240"}, "state": "NV", "@dptid": "115442240"}, "author": [{"ce:given-name": "Tove", "preferred-name": {"ce:given-name": "Tove", "ce:initials": "T.", "ce:surname": "Henriksen", "ce:indexed-name": "Henriksen T."}, "@seq": "3", "ce:initials": "T.", "@_fa": "true", "@type": "auth", "ce:surname": "Henriksen", "@auid": "7102654117", "ce:indexed-name": "Henriksen T."}]}], "citation-title": "Practical management of adverse events related to apomorphine therapy", "abstracts": "\u00a9 2016 Elsevier LtdThe potential for adverse events is often cited as a barrier to the use of subcutaneous apomorphine therapy (intermittent injections and continuous infusion) in the management of Parkinson's disease. However, with proactive management most adverse effects are manageable if reported and tackled early enough. As such, proper clinician and patient awareness of the potential adverse effects is important to minimize their impact on the overall clinical utility of this efficacious antiparkinsonian agent. In this paper, we review the key local and systemic adverse effects reported during apomorphine titration, initiation and long-term treatment, and discuss practical management strategies.", "correspondence": {"affiliation": {"country": "Thailand", "address-part": "1873 Rama 4 Road", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Chulalongkorn Center of Excellence for Parkinson's Disease & Related Disorders"}, {"$": "King Chulalongkorn Memorial Hospital"}]}, "person": {"ce:given-name": "Roongroj", "ce:initials": "R.", "ce:surname": "Bhidayasiri", "ce:indexed-name": "Bhidayasiri R."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Adverse events", "@xml:lang": "eng"}, {"$": "Apomorphine", "@xml:lang": "eng"}, {"$": "Safety", "@xml:lang": "eng"}, {"$": "Tolerability", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "www.elsevier.com/locate/parkreldis", "@type": "email"}}, "translated-sourcetitle": {"$": "Parkinsonism and Related Disorders", "@xml:lang": "eng"}, "volisspag": {"supplement": "Supplement 1", "voliss": {"@volume": "33"}, "pagerange": {"@first": "S42", "@last": "S48"}}, "@type": "j", "sourcetitle": "Parkinsonism and Related Disorders", "publicationdate": {"month": "12", "year": "2016", "date-text": {"@xfab-added": "true", "$": "1 December 2016"}, "day": "01"}, "codencode": "PRDIF", "sourcetitle-abbrev": "Parkinsonism Relat. Disord.", "@country": "gbr", "issn": [{"$": "18735126", "@type": "electronic"}, {"$": "13538020", "@type": "print"}], "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "Elsevier Ltd"}, "@srcid": "18572"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "38", "classification-description": "Adverse Reactions Titles"}, {"classification-code": "8", "classification-description": "Neurology and Neurosurgery"}]}, {"@type": "ASJC", "classification": [{"$": "2808"}, {"$": "2717"}, {"$": "2728"}]}, {"@type": "SUBJABBR", "classification": [{"$": "NEUR"}, {"$": "MEDI"}]}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": {"cas-registry-number": [{"$": "314-19-2"}, {"$": "58-00-4"}], "chemical-name": "apomorphine"}}, {"@source": "nlm", "chemical": [{"chemical-name": "Antiparkinson Agents"}, {"chemical-name": "Apomorphine"}]}]}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "NURSNG"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}, {"$": "MEDL"}], "history": {"date-created": {"@day": "27", "@timestamp": "BST 06:28:06", "@year": "2017", "@month": "01"}}, "itemidlist": {"itemid": [{"$": "613934471", "@idtype": "PUI"}, {"$": "659735687", "@idtype": "CAR-ID"}, {"$": "20170006316", "@idtype": "EMBASE"}, {"$": "2017003199", "@idtype": "NURSNG"}, {"$": "20170013756", "@idtype": "REAXYSCAR"}, {"$": "85007480769", "@idtype": "SCP"}, {"$": "85007480769", "@idtype": "SGR"}, {"$": "620576536", "@idtype": "PUIsecondary"}, {"$": "27919586", "@idtype": "MEDL"}], "ce:pii": "S135380201630462X", "ce:doi": "10.1016/j.parkreldis.2016.11.017"}}, "tail": {"bibliography": {"@refcount": "56", "reference": [{"ref-fulltext": "[1] Poewe, W., Wenning, G.K., Apomorphine: an underutilized therapy for Parkinson's disease. Mov. Disord. 15 (2000), 789\u2013794.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2000"}, "ref-title": {"ref-titletext": "Apomorphine: an underutilized therapy for Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "0033819538", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "15"}, "pagerange": {"@first": "789", "@last": "794"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Poewe", "ce:indexed-name": "Poewe W."}, {"@seq": "2", "ce:initials": "G.K.", "@_fa": "true", "ce:surname": "Wenning", "ce:indexed-name": "Wenning G.K."}]}, "ref-sourcetitle": "Mov. Disord."}}, {"ref-fulltext": "[2] Garcia Ruiz, P.J., Sesar Ignacio, A., Ares Pensado, B., Castro Garcia, A., Alonso Frech, F., Alvarez Lopez, M., Arbelo Gonzalez, J., Baiges Octavio, J., Burguera Hernandez, J.A., Calopa Garriga, M., Campos Blanco, D., Castano Garcia, B., Carballo Cordero, M., Chacon Pena, J., Espino Ibanez, A., Gorospe Onisalde, A., Gimenez-Roldan, S., Granes Ibanez, P., Hernandez Vara, J., Ibanez Alonso, R., Jimenez Jimenez, F.J., Krupinski, J., Kulisevsky Bojarsky, J., Legarda Ramirez, I., Lezcano Garcia, E., Martinez-Castrillo, J.C., Mateo Gonzalez, D., Miquel Rodriguez, F., Mir, P., Munoz Fargas, E., Obeso Inchausti, J., Olivares Romero, J., Olive Plana, J., Otermin Vallejo, P., Pascual Sedano, B., Perez de Colosia Rama, V., Perez Lopez-Fraile, I., Planas Comes, A., Puente Periz, V., Rodriguez Oroz, M.C., Sevillano Garcia, D., Solis Perez, P., Suarez Munoz, J., Vaamonde Gamo, J., Valero Merino, C., Valldeoriola Serra, F., Velazquez Perez, J.M., Yanez Bana, R., Zamarbide Capdepon, I., Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study. Mov. Disord. 23 (2008), 1130\u20131136.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study"}, "refd-itemidlist": {"itemid": {"$": "52649108045", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "1130", "@last": "1136"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.J.", "@_fa": "true", "ce:surname": "Garcia Ruiz", "ce:indexed-name": "Garcia Ruiz P.J."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Sesar Ignacio", "ce:indexed-name": "Sesar Ignacio A."}, {"@seq": "3", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Ares Pensado", "ce:indexed-name": "Ares Pensado B."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Castro Garcia", "ce:indexed-name": "Castro Garcia A."}, {"@seq": "5", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Alonso Frech", "ce:indexed-name": "Alonso Frech F."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Alvarez Lopez", "ce:indexed-name": "Alvarez Lopez M."}, {"@seq": "7", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Arbelo Gonzalez", "ce:indexed-name": "Arbelo Gonzalez J."}, {"@seq": "8", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Baiges Octavio", "ce:indexed-name": "Baiges Octavio J."}, {"@seq": "9", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Burguera Hernandez", "ce:indexed-name": "Burguera Hernandez J.A."}, {"@seq": "10", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Calopa Garriga", "ce:indexed-name": "Calopa Garriga M."}, {"@seq": "11", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Campos Blanco", "ce:indexed-name": "Campos Blanco D."}, {"@seq": "12", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Castano Garcia", "ce:indexed-name": "Castano Garcia B."}, {"@seq": "13", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Carballo Cordero", "ce:indexed-name": "Carballo Cordero M."}, {"@seq": "14", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Chacon Pena", "ce:indexed-name": "Chacon Pena J."}, {"@seq": "15", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Espino Ibanez", "ce:indexed-name": "Espino Ibanez A."}, {"@seq": "16", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Gorospe Onisalde", "ce:indexed-name": "Gorospe Onisalde A."}, {"@seq": "17", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Gimenez-Roldan", "ce:indexed-name": "Gimenez-Roldan S."}, {"@seq": "18", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Granes Ibanez", "ce:indexed-name": "Granes Ibanez P."}, {"@seq": "19", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Hernandez Vara", "ce:indexed-name": "Hernandez Vara J."}, {"@seq": "20", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Ibanez Alonso", "ce:indexed-name": "Ibanez Alonso R."}, {"@seq": "21", "ce:initials": "F.J.", "@_fa": "true", "ce:surname": "Jimenez Jimenez", "ce:indexed-name": "Jimenez Jimenez F.J."}, {"@seq": "22", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Krupinski", "ce:indexed-name": "Krupinski J."}, {"@seq": "23", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Kulisevsky Bojarsky", "ce:indexed-name": "Kulisevsky Bojarsky J."}, {"@seq": "24", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Legarda Ramirez", "ce:indexed-name": "Legarda Ramirez I."}, {"@seq": "25", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Lezcano Garcia", "ce:indexed-name": "Lezcano Garcia E."}, {"@seq": "26", "ce:initials": "J.C.", "@_fa": "true", "ce:surname": "Martinez-Castrillo", "ce:indexed-name": "Martinez-Castrillo J.C."}, {"@seq": "27", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Mateo Gonzalez", "ce:indexed-name": "Mateo Gonzalez D."}, {"@seq": "28", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Miquel Rodriguez", "ce:indexed-name": "Miquel Rodriguez F."}, {"@seq": "29", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Mir", "ce:indexed-name": "Mir P."}, {"@seq": "30", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Munoz Fargas", "ce:indexed-name": "Munoz Fargas E."}, {"@seq": "31", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Obeso Inchausti", "ce:indexed-name": "Obeso Inchausti J."}, {"@seq": "32", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Olivares Romero", "ce:indexed-name": "Olivares Romero J."}, {"@seq": "33", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Olive Plana", "ce:indexed-name": "Olive Plana J."}, {"@seq": "34", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Otermin Vallejo", "ce:indexed-name": "Otermin Vallejo P."}, {"@seq": "35", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Pascual Sedano", "ce:indexed-name": "Pascual Sedano B."}, {"@seq": "36", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Perez de Colosia Rama", "ce:indexed-name": "Perez de Colosia Rama V."}, {"@seq": "37", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Perez Lopez-Fraile", "ce:indexed-name": "Perez Lopez-Fraile I."}, {"@seq": "38", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Planas Comes", "ce:indexed-name": "Planas Comes A."}, {"@seq": "39", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Puente Periz", "ce:indexed-name": "Puente Periz V."}, {"@seq": "40", "ce:initials": "M.C.", "@_fa": "true", "ce:surname": "Rodriguez Oroz", "ce:indexed-name": "Rodriguez Oroz M.C."}, {"@seq": "41", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Sevillano Garcia", "ce:indexed-name": "Sevillano Garcia D."}, {"@seq": "42", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Solis Perez", "ce:indexed-name": "Solis Perez P."}, {"@seq": "43", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Suarez Munoz", "ce:indexed-name": "Suarez Munoz J."}, {"@seq": "44", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Vaamonde Gamo", "ce:indexed-name": "Vaamonde Gamo J."}, {"@seq": "45", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Valero Merino", "ce:indexed-name": "Valero Merino C."}, {"@seq": "46", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Valldeoriola Serra", "ce:indexed-name": "Valldeoriola Serra F."}, {"@seq": "47", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Velazquez Perez", "ce:indexed-name": "Velazquez Perez J.M."}, {"@seq": "48", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Yanez Bana", "ce:indexed-name": "Yanez Bana R."}, {"@seq": "49", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Zamarbide Capdepon", "ce:indexed-name": "Zamarbide Capdepon I."}]}, "ref-sourcetitle": "Mov. Disord."}}, {"ref-fulltext": "[3] Unti, E., Ceravolo, R., Bonuccelli, U., Apomorphine hydrochloride for the treatment of Parkinson's disease. Expert Rev. Neurother. 15 (2015), 723\u2013732.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Apomorphine hydrochloride for the treatment of Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "84933517231", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "15"}, "pagerange": {"@first": "723", "@last": "732"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Unti", "ce:indexed-name": "Unti E."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Ceravolo", "ce:indexed-name": "Ceravolo R."}, {"@seq": "3", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Bonuccelli", "ce:indexed-name": "Bonuccelli U."}]}, "ref-sourcetitle": "Expert Rev. Neurother."}}, {"ref-fulltext": "[4] Henriksen, T., Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians. Neurodegener. Dis. Manag. 4 (2014), 271\u2013282.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians"}, "refd-itemidlist": {"itemid": {"$": "84925884717", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "4"}, "pagerange": {"@first": "271", "@last": "282"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Henriksen", "ce:indexed-name": "Henriksen T."}]}, "ref-sourcetitle": "Neurodegener. Dis. Manag."}}, {"ref-fulltext": "[5] APOKYN Prescribing information. < http://www.apokyn.com/assets/APOKYN_PI.pdf, 2014 (accessed May 2016).", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-website": {"ce:e-address": {"$": "http://www.apokyn.com/assets/APOKYN_PI.pdf", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "85007450731", "@idtype": "SGR"}}, "ref-text": "<, (accessed May 2016).", "ref-authors": {"collaboration": {"@seq": "1", "ce:text": "APOKYN Prescribing information", "ce:indexed-name": "APOKYN Prescribing information"}}}}, {"ref-fulltext": "[6] Dewey, R.B. Jr., Hutton, J.T., LeWitt, P.A., Factor, S.A., A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events. Arch. Neurol. 58 (2001), 1385\u20131392.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events"}, "refd-itemidlist": {"itemid": {"$": "0034843085", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "58"}, "pagerange": {"@first": "1385", "@last": "1392"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.B.", "@_fa": "true", "ce:surname": "Dewey", "ce:suffix": "Jr.", "ce:indexed-name": "Dewey R.B."}, {"@seq": "2", "ce:initials": "J.T.", "@_fa": "true", "ce:surname": "Hutton", "ce:indexed-name": "Hutton J.T."}, {"@seq": "3", "ce:initials": "P.A.", "@_fa": "true", "ce:surname": "LeWitt", "ce:indexed-name": "LeWitt P.A."}, {"@seq": "4", "ce:initials": "S.A.", "@_fa": "true", "ce:surname": "Factor", "ce:indexed-name": "Factor S.A."}]}, "ref-sourcetitle": "Arch. Neurol."}}, {"ref-fulltext": "[7] Pahwa, R., Koller, W.C., Trosch, R.M., Sherry, J.H., Investigators, A.P.O.S., Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose. J. Neurol. Sci. 258 (2007), 137\u2013143.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose"}, "refd-itemidlist": {"itemid": {"$": "34249883912", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "258"}, "pagerange": {"@first": "137", "@last": "143"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Pahwa", "ce:indexed-name": "Pahwa R."}, {"@seq": "2", "ce:initials": "W.C.", "@_fa": "true", "ce:surname": "Koller", "ce:indexed-name": "Koller W.C."}, {"@seq": "3", "ce:initials": "R.M.", "@_fa": "true", "ce:surname": "Trosch", "ce:indexed-name": "Trosch R.M."}, {"@seq": "4", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Sherry", "ce:indexed-name": "Sherry J.H."}, {"@seq": "5", "ce:initials": "A.P.O.S.", "@_fa": "true", "ce:surname": "Investigators", "ce:indexed-name": "Investigators A.P.O.S."}]}, "ref-sourcetitle": "J. Neurol. Sci."}}, {"ref-fulltext": "[8] Pfeiffer, R.F., Gutmann, L., Hull, K.L. Jr., Bottini, P.B., Sherry, J.H., Investigators, A.P.O.S., Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease. Parkinsonism Relat. Disord. 13 (2007), 93\u2013100.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "33847342438", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "93", "@last": "100"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.F.", "@_fa": "true", "ce:surname": "Pfeiffer", "ce:indexed-name": "Pfeiffer R.F."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Gutmann", "ce:indexed-name": "Gutmann L."}, {"@seq": "3", "ce:initials": "K.L.", "@_fa": "true", "ce:surname": "Hull", "ce:suffix": "Jr.", "ce:indexed-name": "Hull K.L."}, {"@seq": "4", "ce:initials": "P.B.", "@_fa": "true", "ce:surname": "Bottini", "ce:indexed-name": "Bottini P.B."}, {"@seq": "5", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Sherry", "ce:indexed-name": "Sherry J.H."}, {"@seq": "6", "ce:initials": "A.P.O.S.", "@_fa": "true", "ce:surname": "Investigators", "ce:indexed-name": "Investigators A.P.O.S."}]}, "ref-sourcetitle": "Parkinsonism Relat. Disord."}}, {"ref-fulltext": "[9] Pietz, K., Hagell, P., Odin, P., Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up. J. Neurol. Neurosurg. Psychiatry 65 (1998), 709\u2013716.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up"}, "refd-itemidlist": {"itemid": {"$": "0031765885", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "65"}, "pagerange": {"@first": "709", "@last": "716"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Pietz", "ce:indexed-name": "Pietz K."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Hagell", "ce:indexed-name": "Hagell P."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Odin", "ce:indexed-name": "Odin P."}]}, "ref-sourcetitle": "J. Neurol. Neurosurg. Psychiatry"}}, {"ref-fulltext": "[10] Odin, P., Hagell, P., Shing, M., Apomorphine in Parkinson's Disease. 2005, Uni-Med Science, Bremen, Germany.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Apomorphine in Parkinson's Disease"}, "refd-itemidlist": {"itemid": {"$": "85007465272", "@idtype": "SGR"}}, "ref-text": "Uni-Med Science Bremen, Germany", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Odin", "ce:indexed-name": "Odin P."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Hagell", "ce:indexed-name": "Hagell P."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Shing", "ce:indexed-name": "Shing M."}]}}}, {"ref-fulltext": "[11] Bhidayasiri, R., Chaudhuri, K.R., LeWitt, P., Martin, A., Boonpang, K., van Laar, T., Effective delivery of apomorphine in the management of Parkinson disease: practical considerations for clinicians and Parkinson nurses. Clin. Neuropharmacol. 38 (2015), 89\u2013103.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Effective delivery of apomorphine in the management of Parkinson disease: practical considerations for clinicians and Parkinson nurses"}, "refd-itemidlist": {"itemid": {"$": "84930080810", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "38"}, "pagerange": {"@first": "89", "@last": "103"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Bhidayasiri", "ce:indexed-name": "Bhidayasiri R."}, {"@seq": "2", "ce:initials": "K.R.", "@_fa": "true", "ce:surname": "Chaudhuri", "ce:indexed-name": "Chaudhuri K.R."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "LeWitt", "ce:indexed-name": "LeWitt P."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Martin", "ce:indexed-name": "Martin A."}, {"@seq": "5", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Boonpang", "ce:indexed-name": "Boonpang K."}, {"@seq": "6", "ce:initials": "T.", "@_fa": "true", "ce:surname": "van Laar", "ce:indexed-name": "van Laar T."}]}, "ref-sourcetitle": "Clin. Neuropharmacol."}}, {"ref-fulltext": "[12] Arnold, G., Schwarz, J., Macher, C., Oertel, W.H., Domperidone is superior to ondansetron in acute apomorphine challenge in previously untreated parkinsonian patients - a double blind study. Parkinsonism Relat. Disord. 3 (1997), 191\u2013193.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Domperidone is superior to ondansetron in acute apomorphine challenge in previously untreated parkinsonian patients - a double blind study"}, "refd-itemidlist": {"itemid": {"$": "0031462033", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "3"}, "pagerange": {"@first": "191", "@last": "193"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Arnold", "ce:indexed-name": "Arnold G."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Schwarz", "ce:indexed-name": "Schwarz J."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Macher", "ce:indexed-name": "Macher C."}, {"@seq": "4", "ce:initials": "W.H.", "@_fa": "true", "ce:surname": "Oertel", "ce:indexed-name": "Oertel W.H."}]}, "ref-sourcetitle": "Parkinsonism Relat. Disord."}}, {"ref-fulltext": "[13] Doggrell, S.A., Hancox, J.C., Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine. Expert Opin. Drug Saf. 13 (2014), 131\u2013138.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine"}, "refd-itemidlist": {"itemid": {"$": "84890479603", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "131", "@last": "138"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.A.", "@_fa": "true", "ce:surname": "Doggrell", "ce:indexed-name": "Doggrell S.A."}, {"@seq": "2", "ce:initials": "J.C.", "@_fa": "true", "ce:surname": "Hancox", "ce:indexed-name": "Hancox J.C."}]}, "ref-sourcetitle": "Expert Opin. Drug Saf."}}, {"ref-fulltext": "[14] Pharmacovigilance Risk Assessment Committee (PRAC) Minutes of the PRAC meeting on 11-14 January 2016, http://www.ema.europe.eu/docs/en_GB/document_library/.../2016/03/WC500202623.pdf, 2016 (accessed May.2016).", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "http://www.ema.europe.eu/docs/en_GB/document_library/.../2016/03/WC500202623.pdf", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "85007472130", "@idtype": "SGR"}}, "ref-text": "(accessed May.2016)", "ref-authors": {"author": [{"@seq": "1", "@_fa": "true", "ce:surname": "Pharmacovigilance Risk Assessment Committee (PRAC) Minutes of the PRAC meeting on 11-14 January 2016", "ce:indexed-name": "Pharmacovigilance Risk Assessment Committee (PRAC) Minutes of the PRAC meeting on 11-14 January 2016"}]}}}, {"ref-fulltext": "[15] ABN recommendations for domperidone, https://gallery.mailchimp.com/7f92fc52090d776e2c33ff870/files/domperidone.pdf, 2016 (accessed May.2016).", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "https://gallery.mailchimp.com/7f92fc52090d776e2c33ff870/files/domperidone.pdf", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "85007421858", "@idtype": "SGR"}}, "ref-text": "(accessed May.2016)", "ref-authors": {"author": [{"@seq": "1", "@_fa": "true", "ce:surname": "ABN recommendations for domperidone", "ce:indexed-name": "ABN recommendations for domperidone"}]}}}, {"ref-fulltext": "[16] Hauser, R.A., Isaacson, S., Clinch, T., Tigan/Apokyn Study, I., Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection. Park. Relat. Disord. 20 (2014), 1171\u20131176.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection"}, "refd-itemidlist": {"itemid": {"$": "84908567180", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "1171", "@last": "1176"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.A.", "@_fa": "true", "ce:surname": "Hauser", "ce:indexed-name": "Hauser R.A."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Isaacson", "ce:indexed-name": "Isaacson S."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Clinch", "ce:indexed-name": "Clinch T."}, {"@seq": "4", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Tigan/Apokyn Study", "ce:indexed-name": "Tigan/Apokyn Study I."}]}, "ref-sourcetitle": "Park. Relat. Disord."}}, {"ref-fulltext": "[17] Hattori, N., Nomoto, M., Study, G., Sustained efficacy of apomorphine in Japanese patients with advanced Parkinson's disease. Parkinsonism Relat. Disord. 20 (2014), 819\u2013823.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Sustained efficacy of apomorphine in Japanese patients with advanced Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "84905241799", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "819", "@last": "823"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Hattori", "ce:indexed-name": "Hattori N."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Nomoto", "ce:indexed-name": "Nomoto M."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Study", "ce:indexed-name": "Study G."}]}, "ref-sourcetitle": "Parkinsonism Relat. Disord."}}, {"ref-fulltext": "[18] Food and Drug Administration, FDA Approved Labeling Text for NDA 021264.", "@id": "18", "ref-info": {"refd-itemidlist": {"itemid": {"$": "85007485498", "@idtype": "SGR"}}, "ref-text": "FDA Approved Labeling Text for NDA 021264.", "ref-authors": {"collaboration": {"@seq": "1", "ce:text": "Food and Drug Administration", "ce:indexed-name": "Food and Drug Administration"}}}}, {"ref-fulltext": "[19] Trenkwalder, C., Chaudhuri, K.R., Garcia Ruiz, P.J., LeWitt, P., Katzenschlager, R., Sixel-Doring, F., Henriksen, T., Sesar, A., Poewe, W.D. Expert Consensus Group for Use of Apomorphine in Parkinson's, Baker, M., Ceballos-Baumann, A., Deuschl, G., Drapier, S., Ebersbach, G., Evans, A., Fernandez, H., Isaacson, S., van Laar, T., Lees, A., Lewis, S., Martinez Castrillo, J.C., Martinez-Martin, P., Odin, P., O'Sullivan, J., Tagaris, G., Wenzel, K., Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease\u2013Clinical practice recommendations. Parkinsonism Relat. Disord. 21 (2015), 1023\u20131030.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease\u2013Clinical practice recommendations"}, "refd-itemidlist": {"itemid": {"$": "84940615116", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "21"}, "pagerange": {"@first": "1023", "@last": "1030"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Trenkwalder", "ce:indexed-name": "Trenkwalder C."}, {"@seq": "2", "ce:initials": "K.R.", "@_fa": "true", "ce:surname": "Chaudhuri", "ce:indexed-name": "Chaudhuri K.R."}, {"@seq": "3", "ce:initials": "P.J.", "@_fa": "true", "ce:surname": "Garcia Ruiz", "ce:indexed-name": "Garcia Ruiz P.J."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "LeWitt", "ce:indexed-name": "LeWitt P."}, {"@seq": "5", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Katzenschlager", "ce:indexed-name": "Katzenschlager R."}, {"@seq": "6", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Sixel-Doring", "ce:indexed-name": "Sixel-Doring F."}, {"@seq": "7", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Henriksen", "ce:indexed-name": "Henriksen T."}, {"@seq": "8", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Sesar", "ce:indexed-name": "Sesar A."}, {"@seq": "9", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Poewe", "ce:indexed-name": "Poewe W."}, {"@seq": "10", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Baker", "ce:indexed-name": "Baker M."}, {"@seq": "11", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Ceballos-Baumann", "ce:indexed-name": "Ceballos-Baumann A."}, {"@seq": "12", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Deuschl", "ce:indexed-name": "Deuschl G."}, {"@seq": "13", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Drapier", "ce:indexed-name": "Drapier S."}, {"@seq": "14", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Ebersbach", "ce:indexed-name": "Ebersbach G."}, {"@seq": "15", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Evans", "ce:indexed-name": "Evans A."}, {"@seq": "16", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Fernandez", "ce:indexed-name": "Fernandez H."}, {"@seq": "17", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Isaacson", "ce:indexed-name": "Isaacson S."}, {"@seq": "18", "ce:initials": "T.", "@_fa": "true", "ce:surname": "van Laar", "ce:indexed-name": "van Laar T."}, {"@seq": "19", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Lees", "ce:indexed-name": "Lees A."}, {"@seq": "20", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Lewis", "ce:indexed-name": "Lewis S."}, {"@seq": "21", "ce:initials": "J.C.", "@_fa": "true", "ce:surname": "Martinez Castrillo", "ce:indexed-name": "Martinez Castrillo J.C."}, {"@seq": "22", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Martinez-Martin", "ce:indexed-name": "Martinez-Martin P."}, {"@seq": "23", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Odin", "ce:indexed-name": "Odin P."}, {"@seq": "24", "ce:initials": "J.", "@_fa": "true", "ce:surname": "O'Sullivan", "ce:indexed-name": "O'Sullivan J."}, {"@seq": "25", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Tagaris", "ce:indexed-name": "Tagaris G."}, {"@seq": "26", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Wenzel", "ce:indexed-name": "Wenzel K."}], "collaboration": {"@seq": "1", "ce:text": "D. Expert Consensus Group for Use of Apomorphine in Parkinson's", "ce:indexed-name": "D. Expert Consensus Group for Use of Apomorphine in Parkinson's"}}, "ref-sourcetitle": "Parkinsonism Relat. Disord."}}, {"ref-fulltext": "[20] Jones, P.K., Shaw, B.H., Raj, S.R., Orthostatic hypotension: managing a difficult problem. Expert Rev. Cardiovasc Ther. 13 (2015), 1263\u20131276.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Orthostatic hypotension: managing a difficult problem"}, "refd-itemidlist": {"itemid": {"$": "84947493696", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "1263", "@last": "1276"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.K.", "@_fa": "true", "ce:surname": "Jones", "ce:indexed-name": "Jones P.K."}, {"@seq": "2", "ce:initials": "B.H.", "@_fa": "true", "ce:surname": "Shaw", "ce:indexed-name": "Shaw B.H."}, {"@seq": "3", "ce:initials": "S.R.", "@_fa": "true", "ce:surname": "Raj", "ce:indexed-name": "Raj S.R."}]}, "ref-sourcetitle": "Expert Rev. Cardiovasc Ther."}}, {"ref-fulltext": "[21] Ardolino, G., D'Adda, E., Nobile-Orazio, E., Recurrent atrial fibrillation after subcutaneous apomorphine. Parkinsonism Relat. Disord. 14 (2008), 173\u2013174 author reply 175.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Recurrent atrial fibrillation after subcutaneous apomorphine"}, "refd-itemidlist": {"itemid": {"$": "44349129925", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "173", "@last": "174"}}, "ref-text": "author reply 175", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Ardolino", "ce:indexed-name": "Ardolino G."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "D'Adda", "ce:indexed-name": "D'Adda E."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Nobile-Orazio", "ce:indexed-name": "Nobile-Orazio E."}]}, "ref-sourcetitle": "Parkinsonism Relat. Disord."}}, {"ref-fulltext": "[22] Stocchi, F., De Pandis, M.F., Delfino, F.A., Anselmo, T., Frongillo, D., Transient atrial fibrillation after subcutaneous apomorphine bolus. Mov. Disord. 11 (1996), 584\u2013585.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "1996"}, "ref-title": {"ref-titletext": "Transient atrial fibrillation after subcutaneous apomorphine bolus"}, "refd-itemidlist": {"itemid": {"$": "0029792150", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "584", "@last": "585"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Stocchi", "ce:indexed-name": "Stocchi F."}, {"@seq": "2", "ce:initials": "M.F.", "@_fa": "true", "ce:surname": "De Pandis", "ce:indexed-name": "De Pandis M.F."}, {"@seq": "3", "ce:initials": "F.A.", "@_fa": "true", "ce:surname": "Delfino", "ce:indexed-name": "Delfino F.A."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Anselmo", "ce:indexed-name": "Anselmo T."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Frongillo", "ce:indexed-name": "Frongillo D."}]}, "ref-sourcetitle": "Mov. Disord."}}, {"ref-fulltext": "[23] Kaminioti, A.N., Nikitas, G.T., Terlis, A.K., Manolis, A.G., Thomaides, T., Panousopoulou, A.N., Ventricular bigeminy after subcutaneous administration of apomorphine in a patient with refractory Parkinson's disease: a case report. J. Mov. Disord. 6 (2013), 9\u201312.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Ventricular bigeminy after subcutaneous administration of apomorphine in a patient with refractory Parkinson's disease: a case report"}, "refd-itemidlist": {"itemid": {"$": "85007462734", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "6"}, "pagerange": {"@first": "9", "@last": "12"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.N.", "@_fa": "true", "ce:surname": "Kaminioti", "ce:indexed-name": "Kaminioti A.N."}, {"@seq": "2", "ce:initials": "G.T.", "@_fa": "true", "ce:surname": "Nikitas", "ce:indexed-name": "Nikitas G.T."}, {"@seq": "3", "ce:initials": "A.K.", "@_fa": "true", "ce:surname": "Terlis", "ce:indexed-name": "Terlis A.K."}, {"@seq": "4", "ce:initials": "A.G.", "@_fa": "true", "ce:surname": "Manolis", "ce:indexed-name": "Manolis A.G."}, {"@seq": "5", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Thomaides", "ce:indexed-name": "Thomaides T."}, {"@seq": "6", "ce:initials": "A.N.", "@_fa": "true", "ce:surname": "Panousopoulou", "ce:indexed-name": "Panousopoulou A.N."}]}, "ref-sourcetitle": "J. Mov. Disord."}}, {"ref-fulltext": "[24] Attanasio, A., Capria, A., Leggiadro, G., Michisanti, M., Cannata, D., Stocchi, F., Ruggieri, S., Transient cardiac arrest during continuous intravenous infusion of apomorphine. Lancet, 336, 1990, 1321.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "1990"}, "ref-title": {"ref-titletext": "Transient cardiac arrest during continuous intravenous infusion of apomorphine"}, "refd-itemidlist": {"itemid": {"$": "0025155663", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "336"}, "pagerange": {"@first": "1321"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Attanasio", "ce:indexed-name": "Attanasio A."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Capria", "ce:indexed-name": "Capria A."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Leggiadro", "ce:indexed-name": "Leggiadro G."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Michisanti", "ce:indexed-name": "Michisanti M."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Cannata", "ce:indexed-name": "Cannata D."}, {"@seq": "6", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Stocchi", "ce:indexed-name": "Stocchi F."}, {"@seq": "7", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ruggieri", "ce:indexed-name": "Ruggieri S."}]}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "[25] Ferreira, J.J., Galitzky, M., Montastruc, J.L., Rascol, O., Sleep attacks and Parkinson's disease treatment. Lancet 355 (2000), 1333\u20131334.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2000"}, "ref-title": {"ref-titletext": "Sleep attacks and Parkinson's disease treatment"}, "refd-itemidlist": {"itemid": {"$": "0034654935", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "355"}, "pagerange": {"@first": "1333", "@last": "1334"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.J.", "@_fa": "true", "ce:surname": "Ferreira", "ce:indexed-name": "Ferreira J.J."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Galitzky", "ce:indexed-name": "Galitzky M."}, {"@seq": "3", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Montastruc", "ce:indexed-name": "Montastruc J.L."}, {"@seq": "4", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Rascol", "ce:indexed-name": "Rascol O."}]}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "[26] Ferreira, J.J., Desboeuf, K., Galitzky, M., Thalamas, C., Brefel-Courbon, C., Fabre, N., Senard, J.M., Montastruc, J.L., Sampaio, C., Rascol, O., Sleep disruption, daytime somnolence and \u2018sleep attacks\u2019 in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers. Eur. J. Neurol. 13 (2006), 209\u2013214.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Sleep disruption, daytime somnolence and \u2018sleep attacks\u2019 in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers"}, "refd-itemidlist": {"itemid": {"$": "33645312090", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "209", "@last": "214"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.J.", "@_fa": "true", "ce:surname": "Ferreira", "ce:indexed-name": "Ferreira J.J."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Desboeuf", "ce:indexed-name": "Desboeuf K."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Galitzky", "ce:indexed-name": "Galitzky M."}, {"@seq": "4", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Thalamas", "ce:indexed-name": "Thalamas C."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Brefel-Courbon", "ce:indexed-name": "Brefel-Courbon C."}, {"@seq": "6", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Fabre", "ce:indexed-name": "Fabre N."}, {"@seq": "7", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Senard", "ce:indexed-name": "Senard J.M."}, {"@seq": "8", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Montastruc", "ce:indexed-name": "Montastruc J.L."}, {"@seq": "9", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Sampaio", "ce:indexed-name": "Sampaio C."}, {"@seq": "10", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Rascol", "ce:indexed-name": "Rascol O."}]}, "ref-sourcetitle": "Eur. J. Neurol."}}, {"ref-fulltext": "[27] Homann, C.N., Suppan, K., Wenzel, K., Ivanic, G., Kriechbaum, N., Ott, E., Sleep attacks with apomorphine. Wien Klin. Wochenschr 114 (2002), 430\u2013431.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Sleep attacks with apomorphine"}, "refd-itemidlist": {"itemid": {"$": "0037076910", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "114"}, "pagerange": {"@first": "430", "@last": "431"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.N.", "@_fa": "true", "ce:surname": "Homann", "ce:indexed-name": "Homann C.N."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Suppan", "ce:indexed-name": "Suppan K."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Wenzel", "ce:indexed-name": "Wenzel K."}, {"@seq": "4", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Ivanic", "ce:indexed-name": "Ivanic G."}, {"@seq": "5", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Kriechbaum", "ce:indexed-name": "Kriechbaum N."}, {"@seq": "6", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Ott", "ce:indexed-name": "Ott E."}]}, "ref-sourcetitle": "Wien Klin. Wochenschr"}}, {"ref-fulltext": "[28] Homann, C.N., Wenzel, K., Suppan, K., Ivanic, G., Kriechbaum, N., Crevenna, R., Ott, E., Sleep attacks in patients taking dopamine agonists: review. BMJ 324 (2002), 1483\u20131487.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Sleep attacks in patients taking dopamine agonists: review"}, "refd-itemidlist": {"itemid": {"$": "0037157539", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "324"}, "pagerange": {"@first": "1483", "@last": "1487"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.N.", "@_fa": "true", "ce:surname": "Homann", "ce:indexed-name": "Homann C.N."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Wenzel", "ce:indexed-name": "Wenzel K."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Suppan", "ce:indexed-name": "Suppan K."}, {"@seq": "4", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Ivanic", "ce:indexed-name": "Ivanic G."}, {"@seq": "5", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Kriechbaum", "ce:indexed-name": "Kriechbaum N."}, {"@seq": "6", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Crevenna", "ce:indexed-name": "Crevenna R."}, {"@seq": "7", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Ott", "ce:indexed-name": "Ott E."}]}, "ref-sourcetitle": "BMJ"}}, {"ref-fulltext": "[29] CPMP Position Statement-European Medicines Agency. http://www.ema.europe.eu/docs/en_GB/document_library/Position.../WC500017653.pdf (accessed May.2016).", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-website": {"ce:e-address": {"$": "http://www.ema.europe.eu/docs/en_GB/document_library/Position.../WC500017653.pdf", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "85007468434", "@idtype": "SGR"}}, "ref-text": "(accessed May.).", "ref-authors": {"collaboration": {"@seq": "1", "ce:text": "CPMP Position Statement-European Medicines Agency", "ce:indexed-name": "CPMP Position Statement-European Medicines Agency"}}}}, {"ref-fulltext": "[30] Johns, M.W., A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991), 540\u2013545.", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "1991"}, "ref-title": {"ref-titletext": "A new method for measuring daytime sleepiness: the Epworth sleepiness scale"}, "refd-itemidlist": {"itemid": {"$": "0026333617", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "540", "@last": "545"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.W.", "@_fa": "true", "ce:surname": "Johns", "ce:indexed-name": "Johns M.W."}]}, "ref-sourcetitle": "Sleep"}}, {"ref-fulltext": "[31] Poltawski, L., Edwards, H., Todd, A., Watson, T., Lees, A., James, C.A., Ultrasound treatment of cutaneous side-effects of infused apomorphine: a randomized controlled pilot study. Mov. Disord. 24 (2009), 115\u2013118.", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Ultrasound treatment of cutaneous side-effects of infused apomorphine: a randomized controlled pilot study"}, "refd-itemidlist": {"itemid": {"$": "61449143704", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "115", "@last": "118"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Poltawski", "ce:indexed-name": "Poltawski L."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Edwards", "ce:indexed-name": "Edwards H."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Todd", "ce:indexed-name": "Todd A."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Watson", "ce:indexed-name": "Watson T."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Lees", "ce:indexed-name": "Lees A."}, {"@seq": "6", "ce:initials": "C.A.", "@_fa": "true", "ce:surname": "James", "ce:indexed-name": "James C.A."}]}, "ref-sourcetitle": "Mov. Disord."}}, {"ref-fulltext": "[32] Acland, K.M., Churchyard, A., Fletcher, C.L., Turner, K., Lees, A., Dowd, P.M., Panniculitis in association with apomorphine infusion. Br. J. Dermatol 138 (1998), 480\u2013482.", "@id": "32", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Panniculitis in association with apomorphine infusion"}, "refd-itemidlist": {"itemid": {"$": "0031896278", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "138"}, "pagerange": {"@first": "480", "@last": "482"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.M.", "@_fa": "true", "ce:surname": "Acland", "ce:indexed-name": "Acland K.M."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Churchyard", "ce:indexed-name": "Churchyard A."}, {"@seq": "3", "ce:initials": "C.L.", "@_fa": "true", "ce:surname": "Fletcher", "ce:indexed-name": "Fletcher C.L."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Turner", "ce:indexed-name": "Turner K."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Lees", "ce:indexed-name": "Lees A."}, {"@seq": "6", "ce:initials": "P.M.", "@_fa": "true", "ce:surname": "Dowd", "ce:indexed-name": "Dowd P.M."}]}, "ref-sourcetitle": "Br. J. Dermatol"}}, {"ref-fulltext": "[33] Grandas, F., Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson's disease. Expert Rev. Neurother. 13 (2013), 1343\u20131353.", "@id": "33", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "84887941096", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "1343", "@last": "1353"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Grandas", "ce:indexed-name": "Grandas F."}]}, "ref-sourcetitle": "Expert Rev. Neurother."}}, {"ref-fulltext": "[34] Poltawski, L., Edwards, H., Todd, A., Watson, T., James, C.A., Lees, A.J., Cutaneous side effects of infused apomorphine: the patient and carer experience. Br. J. Neurosci. Nurs. 4 (2008), 576\u2013580.", "@id": "34", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Cutaneous side effects of infused apomorphine: the patient and carer experience"}, "refd-itemidlist": {"itemid": {"$": "80052393086", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "4"}, "pagerange": {"@first": "576", "@last": "580"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Poltawski", "ce:indexed-name": "Poltawski L."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Edwards", "ce:indexed-name": "Edwards H."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Todd", "ce:indexed-name": "Todd A."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Watson", "ce:indexed-name": "Watson T."}, {"@seq": "5", "ce:initials": "C.A.", "@_fa": "true", "ce:surname": "James", "ce:indexed-name": "James C.A."}, {"@seq": "6", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Lees", "ce:indexed-name": "Lees A.J."}]}, "ref-sourcetitle": "Br. J. Neurosci. Nurs."}}, {"ref-fulltext": "[35] McGee, P., Apomorphine treatment: a nurse's perspective. Adv. Clin. Neurosci. Rehab 2 (2002), 23\u201324.", "@id": "35", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Apomorphine treatment: a nurse's perspective"}, "refd-itemidlist": {"itemid": {"$": "1842433179", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2"}, "pagerange": {"@first": "23", "@last": "24"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "McGee", "ce:indexed-name": "McGee P."}]}, "ref-sourcetitle": "Adv. Clin. Neurosci. Rehab"}}, {"ref-fulltext": "[36] Ruggieri, S., Stocchi, F., Carta, A., Agnoli, A., Side-effects of subcutaneous apomorphine in Parkinson's disease. Lancet, 1, 1989, 566.", "@id": "36", "ref-info": {"ref-publicationyear": {"@first": "1989"}, "ref-title": {"ref-titletext": "Side-effects of subcutaneous apomorphine in Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "0024503423", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "1"}, "pagerange": {"@first": "566"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ruggieri", "ce:indexed-name": "Ruggieri S."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Stocchi", "ce:indexed-name": "Stocchi F."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Carta", "ce:indexed-name": "Carta A."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Agnoli", "ce:indexed-name": "Agnoli A."}]}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "[37] Volkmann, J., Albanese, A., Antonini, A., Chaudhuri, K.R., Clarke, C.E., de Bie, R.M., Deuschl, G., Eggert, K., Houeto, J.L., Kulisevsky, J., Nyholm, D., Odin, P., Ostergaard, K., Poewe, W., Pollak, P., Rabey, J.M., Rascol, O., Ruzicka, E., Samuel, M., Speelman, H., Sydow, O., Valldeoriola, F., van der Linden, C., Oertel, W., Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review. J. Neurol. 260 (2013), 2701\u20132714.", "@id": "37", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review"}, "refd-itemidlist": {"itemid": {"$": "84885108687", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "260"}, "pagerange": {"@first": "2701", "@last": "2714"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Volkmann", "ce:indexed-name": "Volkmann J."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Albanese", "ce:indexed-name": "Albanese A."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Antonini", "ce:indexed-name": "Antonini A."}, {"@seq": "4", "ce:initials": "K.R.", "@_fa": "true", "ce:surname": "Chaudhuri", "ce:indexed-name": "Chaudhuri K.R."}, {"@seq": "5", "ce:initials": "C.E.", "@_fa": "true", "ce:surname": "Clarke", "ce:indexed-name": "Clarke C.E."}, {"@seq": "6", "ce:initials": "R.M.", "@_fa": "true", "ce:surname": "de Bie", "ce:indexed-name": "de Bie R.M."}, {"@seq": "7", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Deuschl", "ce:indexed-name": "Deuschl G."}, {"@seq": "8", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Eggert", "ce:indexed-name": "Eggert K."}, {"@seq": "9", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Houeto", "ce:indexed-name": "Houeto J.L."}, {"@seq": "10", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Kulisevsky", "ce:indexed-name": "Kulisevsky J."}, {"@seq": "11", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Nyholm", "ce:indexed-name": "Nyholm D."}, {"@seq": "12", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Odin", "ce:indexed-name": "Odin P."}, {"@seq": "13", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ostergaard", "ce:indexed-name": "Ostergaard K."}, {"@seq": "14", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Poewe", "ce:indexed-name": "Poewe W."}, {"@seq": "15", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Pollak", "ce:indexed-name": "Pollak P."}, {"@seq": "16", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Rabey", "ce:indexed-name": "Rabey J.M."}, {"@seq": "17", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Rascol", "ce:indexed-name": "Rascol O."}, {"@seq": "18", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Ruzicka", "ce:indexed-name": "Ruzicka E."}, {"@seq": "19", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Samuel", "ce:indexed-name": "Samuel M."}, {"@seq": "20", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Speelman", "ce:indexed-name": "Speelman H."}, {"@seq": "21", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Sydow", "ce:indexed-name": "Sydow O."}, {"@seq": "22", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Valldeoriola", "ce:indexed-name": "Valldeoriola F."}, {"@seq": "23", "ce:initials": "C.", "@_fa": "true", "ce:surname": "van der Linden", "ce:indexed-name": "van der Linden C."}, {"@seq": "24", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Oertel", "ce:indexed-name": "Oertel W."}]}, "ref-sourcetitle": "J. Neurol."}}, {"ref-fulltext": "[38] Ellis, C., Lemmens, G., Parkes, J.D., Abbott, R.J., Pye, I.F., Leigh, P.N., Chaudhuri, K.R., Use of apomorphine in parkinsonian patients with neuropsychiatric complications to oral treatment. Parkinsonism Relat. Disord. 3 (1997), 103\u2013107.", "@id": "38", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Use of apomorphine in parkinsonian patients with neuropsychiatric complications to oral treatment"}, "refd-itemidlist": {"itemid": {"$": "0031426297", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "3"}, "pagerange": {"@first": "103", "@last": "107"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Ellis", "ce:indexed-name": "Ellis C."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Lemmens", "ce:indexed-name": "Lemmens G."}, {"@seq": "3", "ce:initials": "J.D.", "@_fa": "true", "ce:surname": "Parkes", "ce:indexed-name": "Parkes J.D."}, {"@seq": "4", "ce:initials": "R.J.", "@_fa": "true", "ce:surname": "Abbott", "ce:indexed-name": "Abbott R.J."}, {"@seq": "5", "ce:initials": "I.F.", "@_fa": "true", "ce:surname": "Pye", "ce:indexed-name": "Pye I.F."}, {"@seq": "6", "ce:initials": "P.N.", "@_fa": "true", "ce:surname": "Leigh", "ce:indexed-name": "Leigh P.N."}, {"@seq": "7", "ce:initials": "K.R.", "@_fa": "true", "ce:surname": "Chaudhuri", "ce:indexed-name": "Chaudhuri K.R."}]}, "ref-sourcetitle": "Parkinsonism Relat. Disord."}}, {"ref-fulltext": "[39] van Laar, T., Postma, A.G., Drent, M., Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations. Parkinsonism Relat. Disord. 16 (2010), 71\u201372.", "@id": "39", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations"}, "refd-itemidlist": {"itemid": {"$": "74149094215", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "16"}, "pagerange": {"@first": "71", "@last": "72"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "van Laar", "ce:indexed-name": "van Laar T."}, {"@seq": "2", "ce:initials": "A.G.", "@_fa": "true", "ce:surname": "Postma", "ce:indexed-name": "Postma A.G."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Drent", "ce:indexed-name": "Drent M."}]}, "ref-sourcetitle": "Parkinsonism Relat. Disord."}}, {"ref-fulltext": "[40] Drapier, S., Gillioz, A.S., Leray, E., Peron, J., Rouaud, T., Marchand, A., Verin, M., Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications. Parkinsonism Relat. Disord. 18 (2012), 40\u201344.", "@id": "40", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications"}, "refd-itemidlist": {"itemid": {"$": "84655169216", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "18"}, "pagerange": {"@first": "40", "@last": "44"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Drapier", "ce:indexed-name": "Drapier S."}, {"@seq": "2", "ce:initials": "A.S.", "@_fa": "true", "ce:surname": "Gillioz", "ce:indexed-name": "Gillioz A.S."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Leray", "ce:indexed-name": "Leray E."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Peron", "ce:indexed-name": "Peron J."}, {"@seq": "5", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Rouaud", "ce:indexed-name": "Rouaud T."}, {"@seq": "6", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Marchand", "ce:indexed-name": "Marchand A."}, {"@seq": "7", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Verin", "ce:indexed-name": "Verin M."}]}, "ref-sourcetitle": "Parkinsonism Relat. Disord."}}, {"ref-fulltext": "[41] Antonini, A., Isaias, I.U., Rodolfi, G., Landi, A., Natuzzi, F., Siri, C., Pezzoli, G., A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. J. Neurol. 258 (2011), 579\u2013585.", "@id": "41", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation"}, "refd-itemidlist": {"itemid": {"$": "79953806050", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "258"}, "pagerange": {"@first": "579", "@last": "585"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Antonini", "ce:indexed-name": "Antonini A."}, {"@seq": "2", "ce:initials": "I.U.", "@_fa": "true", "ce:surname": "Isaias", "ce:indexed-name": "Isaias I.U."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Rodolfi", "ce:indexed-name": "Rodolfi G."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Landi", "ce:indexed-name": "Landi A."}, {"@seq": "5", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Natuzzi", "ce:indexed-name": "Natuzzi F."}, {"@seq": "6", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Siri", "ce:indexed-name": "Siri C."}, {"@seq": "7", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Pezzoli", "ce:indexed-name": "Pezzoli G."}]}, "ref-sourcetitle": "J. Neurol."}}, {"ref-fulltext": "[42] Antonini, A., Odin, P., Pros and cons of apomorphine and L-dopa continuous infusion in advanced Parkinson's disease. Parkinsonism Relat. Disord. 15:Suppl 4 (2009), S97\u2013S100.", "@id": "42", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Pros and cons of apomorphine and L-dopa continuous infusion in advanced Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "73049100901", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "15"}, "pagerange": {"@first": "S97", "@last": "S100"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Antonini", "ce:indexed-name": "Antonini A."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Odin", "ce:indexed-name": "Odin P."}]}, "ref-sourcetitle": "Parkinsonism Relat. Disord."}}, {"ref-fulltext": "[43] Weintraub, D., Hurtig, H.I., Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies. Am. J. Psychiatry 164 (2007), 1491\u20131498.", "@id": "43", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies"}, "refd-itemidlist": {"itemid": {"$": "35748959362", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "164"}, "pagerange": {"@first": "1491", "@last": "1498"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Weintraub", "ce:indexed-name": "Weintraub D."}, {"@seq": "2", "ce:initials": "H.I.", "@_fa": "true", "ce:surname": "Hurtig", "ce:indexed-name": "Hurtig H.I."}]}, "ref-sourcetitle": "Am. J. Psychiatry"}}, {"ref-fulltext": "[44] Weintraub, D., David, A.S., Evans, A.H., Grant, J.E., Stacy, M., Clinical spectrum of impulse control disorders in Parkinson's disease. Mov. Disord. 30 (2015), 121\u2013127.", "@id": "44", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Clinical spectrum of impulse control disorders in Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "84964267888", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "30"}, "pagerange": {"@first": "121", "@last": "127"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Weintraub", "ce:indexed-name": "Weintraub D."}, {"@seq": "2", "ce:initials": "A.S.", "@_fa": "true", "ce:surname": "David", "ce:indexed-name": "David A.S."}, {"@seq": "3", "ce:initials": "A.H.", "@_fa": "true", "ce:surname": "Evans", "ce:indexed-name": "Evans A.H."}, {"@seq": "4", "ce:initials": "J.E.", "@_fa": "true", "ce:surname": "Grant", "ce:indexed-name": "Grant J.E."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Stacy", "ce:indexed-name": "Stacy M."}]}, "ref-sourcetitle": "Mov. Disord."}}, {"ref-fulltext": "[45] Moore, T.J., Glenmullen, J., Mattison, D.R., Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med. 174 (2014), 1930\u20131933.", "@id": "45", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs"}, "refd-itemidlist": {"itemid": {"$": "84919499802", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "174"}, "pagerange": {"@first": "1930", "@last": "1933"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.J.", "@_fa": "true", "ce:surname": "Moore", "ce:indexed-name": "Moore T.J."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Glenmullen", "ce:indexed-name": "Glenmullen J."}, {"@seq": "3", "ce:initials": "D.R.", "@_fa": "true", "ce:surname": "Mattison", "ce:indexed-name": "Mattison D.R."}]}, "ref-sourcetitle": "JAMA Intern Med."}}, {"ref-fulltext": "[46] Todorova, A., Martin, A., Okai, D., Samuel, M., Brown, R., David, A., Assessment of impulse control disorders in Parkinson's patients with infusion therapies: a single centre experience. Mov. Disord., 28, 2013, S133.", "@id": "46", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Assessment of impulse control disorders in Parkinson's patients with infusion therapies: a single centre experience"}, "refd-itemidlist": {"itemid": {"$": "84889085225", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "28"}, "pagerange": {"@first": "S133"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Todorova", "ce:indexed-name": "Todorova A."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Martin", "ce:indexed-name": "Martin A."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Okai", "ce:indexed-name": "Okai D."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Samuel", "ce:indexed-name": "Samuel M."}, {"@seq": "5", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Brown", "ce:indexed-name": "Brown R."}, {"@seq": "6", "ce:initials": "A.", "@_fa": "true", "ce:surname": "David", "ce:indexed-name": "David A."}]}, "ref-sourcetitle": "Mov. Disord."}}, {"ref-fulltext": "[47] Macphee, G.J., Chaudhuri, K.R., David, A.S., Worth, P., Wood, B., Managing impulse control behaviours in Parkinson's disease: practical guidelines. Br. J. Hosp. Med. (Lond) 74 (2013), 160\u2013166.", "@id": "47", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Managing impulse control behaviours in Parkinson's disease: practical guidelines"}, "refd-itemidlist": {"itemid": {"$": "84875160452", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "74"}, "pagerange": {"@first": "160", "@last": "166"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.J.", "@_fa": "true", "ce:surname": "Macphee", "ce:indexed-name": "Macphee G.J."}, {"@seq": "2", "ce:initials": "K.R.", "@_fa": "true", "ce:surname": "Chaudhuri", "ce:indexed-name": "Chaudhuri K.R."}, {"@seq": "3", "ce:initials": "A.S.", "@_fa": "true", "ce:surname": "David", "ce:indexed-name": "David A.S."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Worth", "ce:indexed-name": "Worth P."}, {"@seq": "5", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Wood", "ce:indexed-name": "Wood B."}]}, "ref-sourcetitle": "Br. J. Hosp. Med. (Lond)"}}, {"ref-fulltext": "[48] Trosch, R.M., Friedman, J.H., Lannon, M.C., Pahwa, R., Smith, D., Seeberger, L.C., O'Brien, C.F., LeWitt, P.A., Koller, W.C., Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience. Mov. Disord. 13 (1998), 377\u2013382.", "@id": "48", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience"}, "refd-itemidlist": {"itemid": {"$": "0031919315", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "377", "@last": "382"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.M.", "@_fa": "true", "ce:surname": "Trosch", "ce:indexed-name": "Trosch R.M."}, {"@seq": "2", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Friedman", "ce:indexed-name": "Friedman J.H."}, {"@seq": "3", "ce:initials": "M.C.", "@_fa": "true", "ce:surname": "Lannon", "ce:indexed-name": "Lannon M.C."}, {"@seq": "4", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Pahwa", "ce:indexed-name": "Pahwa R."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Smith", "ce:indexed-name": "Smith D."}, {"@seq": "6", "ce:initials": "L.C.", "@_fa": "true", "ce:surname": "Seeberger", "ce:indexed-name": "Seeberger L.C."}, {"@seq": "7", "ce:initials": "C.F.", "@_fa": "true", "ce:surname": "O'Brien", "ce:indexed-name": "O'Brien C.F."}, {"@seq": "8", "ce:initials": "P.A.", "@_fa": "true", "ce:surname": "LeWitt", "ce:indexed-name": "LeWitt P.A."}, {"@seq": "9", "ce:initials": "W.C.", "@_fa": "true", "ce:surname": "Koller", "ce:indexed-name": "Koller W.C."}]}, "ref-sourcetitle": "Mov. Disord."}}, {"ref-fulltext": "[49] O'Sullivan, J.D., Lees, A.J., Use of apomorphine in Parkinson's disease. Hosp. Med. 60 (1999), 816\u2013820.", "@id": "49", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "ref-title": {"ref-titletext": "Use of apomorphine in Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "0033219049", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "60"}, "pagerange": {"@first": "816", "@last": "820"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.D.", "@_fa": "true", "ce:surname": "O'Sullivan", "ce:indexed-name": "O'Sullivan J.D."}, {"@seq": "2", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Lees", "ce:indexed-name": "Lees A.J."}]}, "ref-sourcetitle": "Hosp. Med."}}, {"ref-fulltext": "[50] Chaudhuri, K.R., Critchley, P., Abbott, R.J., Pye, I.F., Millac, P.A., Subcutaneous apomorphine for on-off oscillations in Parkinson's disease. Lancet, 2, 1988, 1260.", "@id": "50", "ref-info": {"ref-publicationyear": {"@first": "1988"}, "ref-title": {"ref-titletext": "Subcutaneous apomorphine for on-off oscillations in Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "84921620118", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2"}, "pagerange": {"@first": "1260"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.R.", "@_fa": "true", "ce:surname": "Chaudhuri", "ce:indexed-name": "Chaudhuri K.R."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Critchley", "ce:indexed-name": "Critchley P."}, {"@seq": "3", "ce:initials": "R.J.", "@_fa": "true", "ce:surname": "Abbott", "ce:indexed-name": "Abbott R.J."}, {"@seq": "4", "ce:initials": "I.F.", "@_fa": "true", "ce:surname": "Pye", "ce:indexed-name": "Pye I.F."}, {"@seq": "5", "ce:initials": "P.A.", "@_fa": "true", "ce:surname": "Millac", "ce:indexed-name": "Millac P.A."}]}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "[51] Deleu, D., Hanssens, Y., Northway, M.G., Subcutaneous apomorphine: an evidence-based review of its use in Parkinson's disease. Drugs Aging 21 (2004), 687\u2013709.", "@id": "51", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Subcutaneous apomorphine: an evidence-based review of its use in Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "4644329091", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "21"}, "pagerange": {"@first": "687", "@last": "709"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Deleu", "ce:indexed-name": "Deleu D."}, {"@seq": "2", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Hanssens", "ce:indexed-name": "Hanssens Y."}, {"@seq": "3", "ce:initials": "M.G.", "@_fa": "true", "ce:surname": "Northway", "ce:indexed-name": "Northway M.G."}]}, "ref-sourcetitle": "Drugs Aging"}}, {"ref-fulltext": "[52] O'Sullivan, J.D., Hughes, A.J., Apomorphine-induced penile erections in Parkinson's disease. Mov. Disord. 13 (1998), 536\u2013539.", "@id": "52", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Apomorphine-induced penile erections in Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "0031897683", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "536", "@last": "539"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.D.", "@_fa": "true", "ce:surname": "O'Sullivan", "ce:indexed-name": "O'Sullivan J.D."}, {"@seq": "2", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Hughes", "ce:indexed-name": "Hughes A.J."}]}, "ref-sourcetitle": "Mov. Disord."}}, {"ref-fulltext": "[53] Courty, E., Durif, F., Zenut, M., Courty, P., Lavarenne, J., Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease. Clin. Neuropharmacol. 20 (1997), 140\u2013147.", "@id": "53", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "0030911861", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "140", "@last": "147"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Courty", "ce:indexed-name": "Courty E."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Durif", "ce:indexed-name": "Durif F."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Zenut", "ce:indexed-name": "Zenut M."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Courty", "ce:indexed-name": "Courty P."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Lavarenne", "ce:indexed-name": "Lavarenne J."}]}, "ref-sourcetitle": "Clin. Neuropharmacol."}}, {"ref-fulltext": "[54] Bronner, G., Vodusek, D.B., Management of sexual dysfunction in Parkinson's disease. Ther. Adv. neurological Disord. 4 (2011), 375\u2013383.", "@id": "54", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Management of sexual dysfunction in Parkinson's disease"}, "refd-itemidlist": {"itemid": {"$": "82955213570", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "4"}, "pagerange": {"@first": "375", "@last": "383"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Bronner", "ce:indexed-name": "Bronner G."}, {"@seq": "2", "ce:initials": "D.B.", "@_fa": "true", "ce:surname": "Vodusek", "ce:indexed-name": "Vodusek D.B."}]}, "ref-sourcetitle": "Ther. Adv. neurological Disord."}}, {"ref-fulltext": "[55] Lal, S., Tesfaye, Y., Thavundayil, J.X., Skorzewska, A., Schwartz, G., Effect of time-of-day on the yawning response to apomorphine in normal subjects. Neuropsychobiology 41 (2000), 178\u2013180.", "@id": "55", "ref-info": {"ref-publicationyear": {"@first": "2000"}, "ref-title": {"ref-titletext": "Effect of time-of-day on the yawning response to apomorphine in normal subjects"}, "refd-itemidlist": {"itemid": {"$": "0034063519", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "41"}, "pagerange": {"@first": "178", "@last": "180"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Lal", "ce:indexed-name": "Lal S."}, {"@seq": "2", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Tesfaye", "ce:indexed-name": "Tesfaye Y."}, {"@seq": "3", "ce:initials": "J.X.", "@_fa": "true", "ce:surname": "Thavundayil", "ce:indexed-name": "Thavundayil J.X."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Skorzewska", "ce:indexed-name": "Skorzewska A."}, {"@seq": "5", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Schwartz", "ce:indexed-name": "Schwartz G."}]}, "ref-sourcetitle": "Neuropsychobiology"}}, {"ref-fulltext": "[56] P\u00e9rez, B.V., Portero, T.A., Fern\u00e1ndez, M.S.S., Feliz, C.F., Fern\u00e1ndez, J.d.V., Garc\u00eda-Ruiz, P.J., Apomorphine-induced immune hemolytic anemia. Mov. Disord. Clin. Pract., 2016, 10.1002/mdc3.12373.", "@id": "56", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Apomorphine-induced immune hemolytic anemia"}, "refd-itemidlist": {"itemid": {"$": "85007429162", "@idtype": "SGR"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.V.", "@_fa": "true", "ce:surname": "P\u00e9rez", "ce:indexed-name": "Perez B.V."}, {"@seq": "2", "ce:initials": "T.A.", "@_fa": "true", "ce:surname": "Portero", "ce:indexed-name": "Portero T.A."}, {"@seq": "3", "ce:initials": "M.S.S.", "@_fa": "true", "ce:surname": "Fern\u00e1ndez", "ce:indexed-name": "Fernandez M.S.S."}, {"@seq": "4", "ce:initials": "C.F.", "@_fa": "true", "ce:surname": "Feliz", "ce:indexed-name": "Feliz C.F."}, {"@seq": "5", "ce:initials": "J.D.V.", "@_fa": "true", "ce:surname": "Fern\u00e1ndez", "ce:indexed-name": "Fernandez J.D.V."}, {"@seq": "6", "ce:initials": "P.J.", "@_fa": "true", "ce:surname": "Garc\u00eda-Ruiz", "ce:indexed-name": "Garcia-Ruiz P.J."}]}, "ref-sourcetitle": "Mov. Disord. Clin. Pract."}}]}}}}, "affiliation": [{"affiliation-city": "Tokyo", "@id": "60032116", "affilname": "Juntendo University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032116", "affiliation-country": "Japan"}, {"affiliation-city": "Madrid", "@id": "60026796", "affilname": "Universidad Aut\u00f3noma de Madrid", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026796", "affiliation-country": "Spain"}, {"affiliation-city": "Copenhagen", "@id": "60025840", "affilname": "Bispebjerg Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025840", "affiliation-country": "Denmark"}, {"affiliation-city": "Bangkok", "@id": "60022183", "affilname": "King Chulalongkorn Memorial Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-85007480769", "dc:description": "The potential for adverse events is often cited as a barrier to the use of subcutaneous apomorphine therapy (intermittent injections and continuous infusion) in the management of Parkinson's disease. However, with proactive management most adverse effects are manageable if reported and tackled early enough. As such, proper clinician and patient awareness of the potential adverse effects is important to minimize their impact on the overall clinical utility of this efficacious antiparkinsonian agent. In this paper, we review the key local and systemic adverse effects reported during apomorphine titration, initiation and long-term treatment, and discuss practical management strategies.", "pubmed-id": "27919586", "prism:coverDate": "2016-12-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85007480769", "dc:creator": {"author": [{"ce:given-name": "Roongroj", "preferred-name": {"ce:given-name": "Roongroj", "ce:initials": "R.", "ce:surname": "Bhidayasiri", "ce:indexed-name": "Bhidayasiri R."}, "@seq": "1", "ce:initials": "R.", "@_fa": "true", "affiliation": [{"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}, {"@id": "60032116", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032116"}], "ce:surname": "Bhidayasiri", "@auid": "55882458500", "author-url": "https://api.elsevier.com/content/author/author_id/55882458500", "ce:indexed-name": "Bhidayasiri R."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/85007480769"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85007480769&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85007480769&origin=inward"}], "source-id": "18572", "pii": "S135380201630462X", "citedby-count": "31", "prism:volume": "33", "subtype": "ar", "dc:title": "Practical management of adverse events related to apomorphine therapy", "openaccess": "0", "prism:issn": "18735126 13538020", "publishercopyright": "\u00a9 2016 Elsevier Ltd", "subtypeDescription": "Article", "prism:publicationName": "Parkinsonism and Related Disorders", "prism:pageRange": "S42-S48", "prism:endingPage": "S48", "openaccessFlag": "false", "prism:doi": "10.1016/j.parkreldis.2016.11.017", "prism:startingPage": "S42", "dc:identifier": "SCOPUS_ID:85007480769", "dc:publisher": "Elsevier Ltd"}, "idxterms": {"mainterm": [{"$": "Animals", "@weight": "b", "@candidate": "n"}, {"$": "Antiparkinson Agents", "@weight": "b", "@candidate": "n"}, {"$": "Apomorphine", "@weight": "b", "@candidate": "n"}, {"$": "Arrhythmias, Cardiac", "@weight": "b", "@candidate": "n"}, {"$": "Disease Management", "@weight": "a", "@candidate": "n"}, {"$": "Dyskinesia, Drug-Induced", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Hypotension, Orthostatic", "@weight": "b", "@candidate": "n"}, {"$": "Parkinson Disease", "@weight": "b", "@candidate": "n"}, {"$": "Vomiting", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Adverse events"}, {"@_fa": "true", "$": "Apomorphine"}, {"@_fa": "true", "$": "Safety"}, {"@_fa": "true", "$": "Tolerability"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Neurology", "@code": "2808", "@abbrev": "NEUR"}, {"@_fa": "true", "$": "Geriatrics and Gerontology", "@code": "2717", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Neurology (clinical)", "@code": "2728", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Roongroj", "preferred-name": {"ce:given-name": "Roongroj", "ce:initials": "R.", "ce:surname": "Bhidayasiri", "ce:indexed-name": "Bhidayasiri R."}, "@seq": "1", "ce:initials": "R.", "@_fa": "true", "affiliation": [{"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}, {"@id": "60032116", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032116"}], "ce:surname": "Bhidayasiri", "@auid": "55882458500", "author-url": "https://api.elsevier.com/content/author/author_id/55882458500", "ce:indexed-name": "Bhidayasiri R."}, {"ce:given-name": "Pedro J.", "preferred-name": {"ce:given-name": "Pedro J.", "ce:initials": "P.J.", "ce:surname": "Garcia Ruiz", "ce:indexed-name": "Garcia Ruiz P.J."}, "@seq": "2", "ce:initials": "P.J.", "@_fa": "true", "affiliation": {"@id": "60026796", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026796"}, "ce:surname": "Garcia Ruiz", "@auid": "7005540950", "author-url": "https://api.elsevier.com/content/author/author_id/7005540950", "ce:indexed-name": "Garcia Ruiz P.J."}, {"ce:given-name": "Tove", "preferred-name": {"ce:given-name": "Tove", "ce:initials": "T.", "ce:surname": "Henriksen", "ce:indexed-name": "Henriksen T."}, "@seq": "3", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60025840", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025840"}, "ce:surname": "Henriksen", "@auid": "7102654117", "author-url": "https://api.elsevier.com/content/author/author_id/7102654117", "ce:indexed-name": "Henriksen T."}]}}}